DHR: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/e7ab7f2c-3977-4240-b028-8b20cb6f3e2e/","filing_uuid":"e7ab7f2c-3977-4240-b028-8b20cb6f3e2e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e7ab7f2c-3977-4240-b028-8b20cb6f3e2e/print/","filing_document_content_type":"text/html","income":"36000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"R. Reed Skaggs, Chief Strategy and Business Officer","dt_posted":"2026-07-16T18:17:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"440 1st Street NW","registrant_address_2":"Suite 700","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":22781,"url":"https://lda.gov/api/v1/registrants/22781/","house_registrant_id":30442,"name":"LEWIS-BURKE ASSOCIATES, LLC","description":"Lobbying and Consulting Firm","address_1":"440 1st Street NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"REED SKAGGS","contact_telephone":"+1 202-289-7475","dt_updated":"2026-07-13T12:18:35.067037-04:00"},"client":{"id":73166,"url":"https://lda.gov/api/v1/clients/73166/","client_id":73166,"name":"DANAHER CORPORATION","general_description":"For-profit Company - Biomedical Products","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-05-08"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues pertaining to the regulation of cell and gene therapy products. Issues pertaining to the biomedical research enterprise.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152329,"prefix":"ms","prefix_display":"MS.","first_name":"ANJALI","nickname":null,"middle_name":"HELENA","last_name":"TADAVARTHY","suffix":null,"suffix_display":null},"covered_position":"Paid Intern - Washington DC Office of Senator Tina Smith","new":false},{"lobbyist":{"id":152328,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ANTHONY","last_name":"PETERSON","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Sen. Leg. Assistant, Leg. Assistant, Leg. Correspondent/Digital Media Specialist, Staff Assistant, Intern, Congressman Peter J. Visclosky","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}